Sonnet BioTherapeutics Holdings, Inc.

Develops targeted cytokine therapies for cancer using a proprietary albumin-binding platform.

SONN | US

Overview

Corporate Details

ISIN(s):: US83548R1059
LEI:
Country:: United States of America
Address:: 100 OVERLOOK CENTER, 8540 PRINCETON
Website:: https://www.sonnetbio.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company that develops targeted biologic medicines. The company's core technology is its proprietary Fully Human Albumin-Binding (FHAB™) platform, which utilizes a single-chain antibody fragment (scFv) that binds to the body's own albumin. This 'hitch-hiking' mechanism is designed to deliver cytokine payloads directly to tumor tissues, enhancing drug penetration, retention, and local activation. Sonnet's therapeutic goal is to convert immunologically 'cold' tumors into 'hot' tumors, thereby making them more responsive to treatment. The company's pipeline consists of several cytokine-derived therapeutic candidates in clinical development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Sonnet BioTherapeutics Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sonnet BioTherapeutics Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Sonnet BioTherapeutics Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Camurus Develops long-acting medicines for severe chronic diseases using advanced drug delivery.	Sweden	CAMX
CanBas Co.,Ltd. Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.	Japan	4575
Candel Therapeutics, Inc. Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.	United States of America	CADL
Can-Fite BioPharma Ltd. Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.	Israel	CANF
Cannovum Cannabis AG Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.	Germany	27N0
Canopy Growth Corp Produces diverse cannabis products for medical and recreational markets globally.	United States of America	CGC
Cantourage Group SE A European platform producing and distributing medical cannabis products to pharmacies.	Germany	HIGH
CAPRICOR THERAPEUTICS, INC. Develops cell and exosome-based therapeutics for rare diseases like Duchenne muscular dystrophy.	United States of America	CAPR
CAREGEN CO.,LTD. Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.	South Korea	214370
Caribou Biosciences, Inc. Uses CRISPR genome editing to create off-the-shelf CAR-T cell therapies for cancer.	United States of America	CRBU